Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2022-05-13 2022-05-13
Drug Identification Number 00030937 00030937
Brand name PROVERA 5MG TABLETS PROVERA 5MG TABLETS
Common or Proper name PROVERA PROVERA
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1x100 BTL 1x100 BTL
ATC code G03DA G03DA
ATC description PROGESTOGENS PROGESTOGENS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-03-18 2022-03-18
Estimated end date 2022-05-27 2022-05-27
Actual end date 2022-05-11 2022-05-11
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments